BENDIRA Trademark

Trademark Overview

On Tuesday, February 22, 2011, a trademark application was filed for BENDIRA with the United States Patent and Trademark Office. The USPTO has given the BENDIRA trademark a serial number of 85248303. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 29, 2014. This trademark is owned by Glaxo Group Limited. The BENDIRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
bendira

General Information

Serial Number85248303
Word MarkBENDIRA
Filing DateTuesday, February 22, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 29, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 28, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 25, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, September 29, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 29, 2014ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 5, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 4, 2014EXTENSION 5 GRANTED
Monday, February 17, 2014EXTENSION 5 FILED
Monday, February 17, 2014TEAS EXTENSION RECEIVED
Tuesday, September 17, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, September 14, 2013EXTENSION 4 GRANTED
Wednesday, August 14, 2013EXTENSION 4 FILED
Monday, September 9, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 14, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 15, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 14, 2013EXTENSION 3 GRANTED
Tuesday, February 12, 2013EXTENSION 3 FILED
Tuesday, February 12, 2013TEAS EXTENSION RECEIVED
Friday, August 24, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 23, 2012EXTENSION 2 GRANTED
Tuesday, August 14, 2012EXTENSION 2 FILED
Wednesday, August 22, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 14, 2012TEAS EXTENSION RECEIVED
Saturday, January 28, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 26, 2012EXTENSION 1 GRANTED
Thursday, January 26, 2012EXTENSION 1 FILED
Thursday, January 26, 2012TEAS EXTENSION RECEIVED
Tuesday, August 23, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 28, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 28, 2011PUBLISHED FOR OPPOSITION
Wednesday, May 25, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 24, 2011ASSIGNED TO EXAMINER
Friday, February 25, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 25, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

bendira pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological